608 related articles for article (PubMed ID: 24119986)
1. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
[TBL] [Abstract][Full Text] [Related]
2. Conversion to sirolimus and mycophenolate can attenuate the progression of bronchiolitis obliterans syndrome and improves renal function after lung transplantation.
Groetzner J; Wittwer T; Kaczmarek I; Ueberfuhr P; Strauch J; Nagib R; Meiser B; Franke U; Reichart B; Wahlers T
Transplantation; 2006 Feb; 81(3):355-60. PubMed ID: 16477220
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients.
McNeil K; Glanville AR; Wahlers T; Knoop C; Speich R; Mamelok RD; Maurer J; Ives J; Corris PA
Transplantation; 2006 Apr; 81(7):998-1003. PubMed ID: 16612275
[TBL] [Abstract][Full Text] [Related]
4. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
[TBL] [Abstract][Full Text] [Related]
5. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.
Guethoff S; Stroeh K; Grinninger C; Koenig MA; Kleinert EC; Rieger A; Mayr T; von Ziegler F; Reichart B; Hagl C; Schramm R; Kaczmarek I; Meiser BM
J Heart Lung Transplant; 2015 May; 34(5):634-42. PubMed ID: 25701373
[TBL] [Abstract][Full Text] [Related]
6. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.
Bhorade S; Ahya VN; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Alex CG; Bag R; Deoliveira NC; Husain A; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Garrity E
Am J Respir Crit Care Med; 2011 Feb; 183(3):379-87. PubMed ID: 20833822
[TBL] [Abstract][Full Text] [Related]
7. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
[TBL] [Abstract][Full Text] [Related]
10. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation.
Speich R; Schneider S; Hofer M; Irani S; Vogt P; Weder W; Boehler A
Pulm Pharmacol Ther; 2010 Oct; 23(5):445-9. PubMed ID: 20394831
[TBL] [Abstract][Full Text] [Related]
12. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus.
Villanueva J; Boukhamseen A; Bhorade SM
J Heart Lung Transplant; 2005 Apr; 24(4):421-5. PubMed ID: 15797743
[TBL] [Abstract][Full Text] [Related]
13. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
[TBL] [Abstract][Full Text] [Related]
15. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant.
Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A
JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
Celik MR; Lederer DJ; Wilt J; Eser D; Bacchetta M; D'Ovidio F; Sonett JR; Arcasoy SM
J Heart Lung Transplant; 2009 Jul; 28(7):697-703. PubMed ID: 19560698
[TBL] [Abstract][Full Text] [Related]
17. Lung transplantation: a decade of experience.
Moffatt SD; Demers P; Robbins RC; Doyle R; Wienacker A; Henig N; Theodore J; Reitz BA; Whyte RI
J Heart Lung Transplant; 2005 Feb; 24(2):145-51. PubMed ID: 15701428
[TBL] [Abstract][Full Text] [Related]
18. Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series.
Lovric S; Kielstein JT; Kayser D; Bröcker V; Becker JU; Hiss M; Schiffer M; Sommerwerck U; Haller H; Strüber M; Welte T; Gottlieb J
Nephrol Dial Transplant; 2011 Sep; 26(9):3032-8. PubMed ID: 21310739
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients.
Dhillon GS; Valentine VG; Levitt J; Patel P; Gupta MR; Duncan SR; Seoane L; Weill D
Clin Transplant; 2012; 26(1):105-10. PubMed ID: 21352378
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis.
Fan Y; Xiao YB; Weng YG
Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]